GlassScriptPhysician profile
Afzaal Iqbal
NPI 1861782674
$11,345.61
in general payments reported to CMS, 2019-2025
48 companies · $971 in 2025
The $971 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,966 · 2020: $1,120 · 2021: $1,619 · 2022: $2,560 · 2023: $432 · 2024: $1,677 · 2025: $971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,526 · Travel and Lodging: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,526.26 |
| Travel and Lodging | $553.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,704.24 | 2019-2025 | Eterna, Proclaim, Lamitrode Tripole |
| Boston Scientific Corporation | $2,435.88 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Vertiflex, INC. | $1,912.79 | 2019 | |
| Abbvie INC. | $1,131.77 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $304.82 | 2020-2025 | Belbuca |
| Nevro Corp. | $253.52 | 2019-2024 | Senza |
| Allergan, INC. | $231.53 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $175.66 | 2021 | |
| Medtronic USA, INC. | $169.87 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $161.65 | 2020-2025 | Ztlido |
| Amgen INC. | $115.38 | 2021-2025 | Prolia, Evenity |
| Spinal Simplicity, LLC | $113.15 | 2021-2025 | Ha Minuteman G3-R |
| Saluda Medical Americas, INC. | $109.73 | 2023-2024 | Evoke Scs, Evoke |
| Lilly USA, LLC | $100.96 | 2019-2025 | Zepbound |
| West Therapeutics Development, LLC | $95.71 | 2020-2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Afzaal Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.